Vaxcyte (PCVX) Other Non Operating Income (2019 - 2026)
Vaxcyte (PCVX) posted quarterly Other Non Operating Income of -$1.4 million for Q1 2026, down 119.36% year-over-year from $7.1 million in Q1 2025, and down 204.3% quarter-over-quarter from $1.3 million in Q4 2025.
Vaxcyte (PCVX) Other Non Operating Income (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Other Non Operating Income for 8 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 119.36% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at $28.8 million (up 478.57% YoY), while the FY2025 annual figure was $37.3 million, up 953.23% from the prior year.
- Other Non Operating Income eased to -$1.4 million in Q1 2026 per PCVX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $28.6 million in Q2 2025 and bottomed at -$47.0 million in Q4 2023.
- Historically, Other Non Operating Income has averaged $2.4 million across 5 years, with a median of $465000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 3498.04% — and 2025, when it jumped 6044.73%.
- Vaxcyte's Other Non Operating Income stood at $8.5 million in 2022, then tumbled by 651.82% to -$47.0 million in 2023, then jumped by 75.83% to -$11.4 million in 2024, then soared by 111.65% to $1.3 million in 2025, then tumbled by 204.3% to -$1.4 million in 2026.
- Business Quant data shows PCVX's Other Non Operating Income at -$1.4 million in Q1 2026, $1.3 million in Q4 2025, and $291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.28 Mn |
| Mar 31, 2026 | -1.38 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 28.57 Mn |
| Mar 31, 2025 | 7.14 Mn |
| Dec 31, 2024 | -11.37 Mn |
| Sep 30, 2024 | 8.74 Mn |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | -47.03 Mn |
| Sep 30, 2023 | 20.36 Mn |
| Jun 30, 2023 | 18.81 Mn |
| Mar 31, 2023 | 10.73 Mn |
| Dec 31, 2022 | 8.52 Mn |
| Sep 30, 2022 | -687,000.00 |
| Jun 30, 2022 | -1.73 Mn |
| Mar 31, 2022 | 235,000.00 |
| Dec 31, 2021 | 1.28 Mn |
| Sep 30, 2021 | -54,000.00 |